Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants

[ihatelexapro444]

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122283/

"SAs were associated with an increased risk for ED (cOR = 3.6, p < 0.000001, 95% CI  2.8–4.8), which remained significant after adjusting for age, SES, BMI, depression and anxiety (aOR = 3.2, p < 0.000001, 95% CI  2.3–4.4). The risk for PSSD was 1 in 216 patients (0.46%) treated with SAs. The prevalence of PSSD was 4.3 per 100,000."